DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation

Renli Huang1, Cheng Wu2, Jialing Wen3

  • 1Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Cancer Medicine
|May 11, 2022
PubMed
Abstract

Insights

Actin cytoskeleton genes impact colorectal cancer (CRC) progression. Diaphanous-related formin 3 (DIAPH3) is downregulated in CRC, and its knockdown promotes cancer cell proliferation and migration by affecting EGFR signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Actin cytoskeleton dynamics are crucial for colorectal cancer (CRC) cell proliferation and migration.
  • The specific roles of actin cytoskeleton genes (ACGs) in CRC progression and their potential as therapeutic targets remain largely unexplored.

Purpose of the Study:

  • To investigate the role of hub prognosis-related ACGs, specifically Diaphanous-related formin 3 (DIAPH3), in colorectal cancer (CRC).
  • To evaluate DIAPH3 as a potential novel therapeutic target and prognostic biomarker in CRC.

Main Methods:

  • Utilized the Kyoto Encyclopedia of Genes and Genomes (KEGG) ACGs gene set for patient grouping and Cox regression analysis to identify prognostic ACGs.
  • Assessed DIAPH3 expression in CRC and its functional role using shRNA in CRC cell lines (KM12, SW480).
  • Analyzed epidermal growth factor receptor (EGFR) activation via western blot and immunofluorescence.

Main Results:

  • Actin cytoskeleton function is a significant prognostic factor in CRC, correlating with T stage and lymph node metastasis.
  • A prognostic model based on four ACGs demonstrated moderate 1-year survival prediction (AUC = 0.71).
  • DIAPH3 was found to be downregulated in CRC; its knockdown enhanced CRC cell proliferation and migration, and increased EGFR phosphorylation by inhibiting lysosomal transport.

Conclusions:

  • ACGs are significant in CRC invasion and prognosis prediction.
  • DIAPH3 shows potential as a novel prognostic biomarker for CRC.
  • DIAPH3 may inhibit CRC progression by regulating EGFR degradation.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K